Stay updated on Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial
Sign up to get notified when there's something new on the Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial page.

Latest updates to the Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial page
- Check3 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe Publications section now notes that entries are voluntarily provided and auto-filled from PubMed, and the revision tag shows v3.3.2. These edits do not affect the study design, results, or eligibility.SummaryDifference0.2%

- Check39 days agoChange DetectedThe government funding lapse disclaimer was removed from the page. The page no longer displays the funding-status notice directing users to other government sources.SummaryDifference0.4%

- Check53 days agoChange DetectedScreenshots show no significant changes to the study details, eligibility criteria, or layout; the page content and purpose remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%

- Check89 days agoChange Detected- Updated terminology from 'Plasma cell myeloma' to 'Multiple myeloma'. - Added new version tag 'Revision: v3.1.0'. - Removed outdated items: 'Vaccines, Combined', 'Heptavalent Pneumococcal Conjugate Vaccine', and 'Revision: v3.0.2'.SummaryDifference0.6%

Stay in the know with updates to Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pneumococcal Vaccination in Myeloma Patients on Novel Agents Clinical Trial page.